- UID
- 9
- Online time
- Hours
- Posts
- Reg time
- 21-8-2017
- Last login
- 1-1-1970
|
With countries struggling to contain the coronavirus epidemic, a possible drug combination developed by physicians in Kansas City could emerge as a key breakthrough.
Doctors are employing two drugs in combination — hydroxychloroquine (HC) and azithromycin (AZ) — to treat Covid-19 patients, writes Dr Jeff Colyer in an article for the Washington Post. The course of medical treatment being used was reported in a recently conducted open-label trial in Marseille, France, which was subsequently updated on March 26, and which the doctors may further modify, the article said.
Read more here
|
|